 | • レポートコード：D005-00152 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、がん腫瘍プロファイリングの世界市場を広く調査・分析し、今後の市場展望をまとめております。がん腫瘍プロファイリングの種類別市場規模（次世代シーケンシング（NGS）、ポリメラーゼ連鎖反応（PCR）、免疫組織化学（IHC）、In Situハイブリダイゼーション（ISH）、マイクロアレイ、その他）、用途別市場規模（オーダメイド医療、診断、バイオマーカー探索、予後、研究用）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Qiagen N.V.、Hologic Gen-Probe、Illumina Inc.、Roche Molecular Systems Inc.、Genomic Health Inc.、Abott Molecular、Siemens Healthineers、HTG Molecular Diagnostic、NeoGenomics Laboratories、BD Biosciences、V., Strand、Agendia、Claris Life Sciences、ApoCell、Foundation Medicine, Inc、Personal Genome Diagnostics, Inc.、GenScript、Contextual Genomics、Perthera, Inc. ・地域別グローバル市場分析 2015年-2020年 ・がん腫瘍プロファイリングの北米市場（アメリカ、カナダ、メキシコ） ・がん腫瘍プロファイリングのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・がん腫瘍プロファイリングのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・がん腫瘍プロファイリングの南米市場（ブラジル、アルゼンチン） ・がん腫瘍プロファイリングの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：次世代シーケンシング（NGS）、ポリメラーゼ連鎖反応（PCR）、免疫組織化学（IHC）、In Situハイブリダイゼーション（ISH）、マイクロアレイ、その他 ・用途別分析：オーダメイド医療、診断、バイオマーカー探索、予後、研究用 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Cancer Tumor Profiling market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.0% in the forecast period of 2020 to 2025 and will expected to reach USD 54970 million by 2025, from USD 37570 million in 2019.
The Cancer Tumor Profiling market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Cancer Tumor Profiling market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cancer Tumor Profiling market has been segmented into:
Next-generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Microarray
Others
By Application, Cancer Tumor Profiling has been segmented into:
Personalized Medicine
Diagnostics
Biomarker Discovery
Prognostics
Research Applications
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cancer Tumor Profiling market presented in the report. This section sheds light on the sales growth of different regional and country-level Cancer Tumor Profiling markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cancer Tumor Profiling market.
The report offers in-depth assessment of the growth and other aspects of the Cancer Tumor Profiling market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Cancer Tumor Profiling Market Share Analysis
Cancer Tumor Profiling competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cancer Tumor Profiling sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cancer Tumor Profiling sales, revenue and market share for each player covered in this report.
The major players covered in Cancer Tumor Profiling are:
Qiagen N.V.
Hologic Gen-Probe
Illumina Inc.
Roche Molecular Systems Inc.
Genomic Health Inc.
Abott Molecular
Siemens Healthineers
HTG Molecular Diagnostic
NeoGenomics Laboratories
BD Biosciences
V., Strand
Agendia
Claris Life Sciences
ApoCell
Foundation Medicine, Inc
Personal Genome Diagnostics, Inc.
GenScript
Contextual Genomics
Perthera, Inc.
Table of Contents
1 Cancer Tumor Profiling Market Overview
1.1 Product Overview and Scope of Cancer Tumor Profiling
1.2 Classification of Cancer Tumor Profiling by Type
1.2.1 Global Cancer Tumor Profiling Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Cancer Tumor Profiling Revenue Market Share by Type in 2019
1.2.3 Next-generation Sequencing (NGS)
1.2.4 Polymerase Chain Reaction (PCR)
1.2.5 Immunohistochemistry (IHC)
1.2.6 In Situ Hybridization (ISH)
1.2.7 Microarray
1.2.8 Others
1.3 Global Cancer Tumor Profiling Market by Application
1.3.1 Overview: Global Cancer Tumor Profiling Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Personalized Medicine
1.3.3 Diagnostics
1.3.4 Biomarker Discovery
1.3.5 Prognostics
1.3.6 Research Applications
1.4 Global Cancer Tumor Profiling Market by Regions
1.4.1 Global Cancer Tumor Profiling Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Cancer Tumor Profiling (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Cancer Tumor Profiling Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Cancer Tumor Profiling Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Tumor Profiling Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Cancer Tumor Profiling Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Tumor Profiling Status and Prospect (2015-2025)
2 Company Profiles
2.1 Qiagen N.V.
2.1.1 Qiagen N.V. Details
2.1.2 Qiagen N.V. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Qiagen N.V. SWOT Analysis
2.1.4 Qiagen N.V. Product and Services
2.1.5 Qiagen N.V. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.2 Hologic Gen-Probe
2.2.1 Hologic Gen-Probe Details
2.2.2 Hologic Gen-Probe Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Hologic Gen-Probe SWOT Analysis
2.2.4 Hologic Gen-Probe Product and Services
2.2.5 Hologic Gen-Probe Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.3 Illumina Inc.
2.3.1 Illumina Inc. Details
2.3.2 Illumina Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Illumina Inc. SWOT Analysis
2.3.4 Illumina Inc. Product and Services
2.3.5 Illumina Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche Molecular Systems Inc.
2.4.1 Roche Molecular Systems Inc. Details
2.4.2 Roche Molecular Systems Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Roche Molecular Systems Inc. SWOT Analysis
2.4.4 Roche Molecular Systems Inc. Product and Services
2.4.5 Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.5 Genomic Health Inc.
2.5.1 Genomic Health Inc. Details
2.5.2 Genomic Health Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Genomic Health Inc. SWOT Analysis
2.5.4 Genomic Health Inc. Product and Services
2.5.5 Genomic Health Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.6 Abott Molecular
2.6.1 Abott Molecular Details
2.6.2 Abott Molecular Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Abott Molecular SWOT Analysis
2.6.4 Abott Molecular Product and Services
2.6.5 Abott Molecular Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.7 Siemens Healthineers
2.7.1 Siemens Healthineers Details
2.7.2 Siemens Healthineers Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Siemens Healthineers SWOT Analysis
2.7.4 Siemens Healthineers Product and Services
2.7.5 Siemens Healthineers Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.8 HTG Molecular Diagnostic
2.8.1 HTG Molecular Diagnostic Details
2.8.2 HTG Molecular Diagnostic Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 HTG Molecular Diagnostic SWOT Analysis
2.8.4 HTG Molecular Diagnostic Product and Services
2.8.5 HTG Molecular Diagnostic Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.9 NeoGenomics Laboratories
2.9.1 NeoGenomics Laboratories Details
2.9.2 NeoGenomics Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 NeoGenomics Laboratories SWOT Analysis
2.9.4 NeoGenomics Laboratories Product and Services
2.9.5 NeoGenomics Laboratories Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.10 BD Biosciences
2.10.1 BD Biosciences Details
2.10.2 BD Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 BD Biosciences SWOT Analysis
2.10.4 BD Biosciences Product and Services
2.10.5 BD Biosciences Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.11 V., Strand
2.11.1 V., Strand Details
2.11.2 V., Strand Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 V., Strand SWOT Analysis
2.11.4 V., Strand Product and Services
2.11.5 V., Strand Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.12 Agendia
2.12.1 Agendia Details
2.12.2 Agendia Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Agendia SWOT Analysis
2.12.4 Agendia Product and Services
2.12.5 Agendia Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.13 Claris Life Sciences
2.13.1 Claris Life Sciences Details
2.13.2 Claris Life Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Claris Life Sciences SWOT Analysis
2.13.4 Claris Life Sciences Product and Services
2.13.5 Claris Life Sciences Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.14 ApoCell
2.14.1 ApoCell Details
2.14.2 ApoCell Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 ApoCell SWOT Analysis
2.14.4 ApoCell Product and Services
2.14.5 ApoCell Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.15 Foundation Medicine, Inc
2.15.1 Foundation Medicine, Inc Details
2.15.2 Foundation Medicine, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Foundation Medicine, Inc SWOT Analysis
2.15.4 Foundation Medicine, Inc Product and Services
2.15.5 Foundation Medicine, Inc Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.16 Personal Genome Diagnostics, Inc.
2.16.1 Personal Genome Diagnostics, Inc. Details
2.16.2 Personal Genome Diagnostics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Personal Genome Diagnostics, Inc. SWOT Analysis
2.16.4 Personal Genome Diagnostics, Inc. Product and Services
2.16.5 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.17 GenScript
2.17.1 GenScript Details
2.17.2 GenScript Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 GenScript SWOT Analysis
2.17.4 GenScript Product and Services
2.17.5 GenScript Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.18 Contextual Genomics
2.18.1 Contextual Genomics Details
2.18.2 Contextual Genomics Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Contextual Genomics SWOT Analysis
2.18.4 Contextual Genomics Product and Services
2.18.3 Contextual Genomics Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
2.19 Perthera, Inc.
2.19.1 Perthera, Inc. Details
2.19.2 Perthera, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Perthera, Inc. SWOT Analysis
2.19.4 Perthera, Inc. Product and Services
2.19.5 Perthera, Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Cancer Tumor Profiling Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Cancer Tumor Profiling Players Market Share
3.2.2 Top 10 Cancer Tumor Profiling Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Cancer Tumor Profiling Revenue and Market Share by Regions
4.2 North America Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
4.3 Europe Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
4.5 South America Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
5 North America Cancer Tumor Profiling Revenue by Countries
5.1 North America Cancer Tumor Profiling Revenue by Countries (2015-2020)
5.2 USA Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
5.3 Canada Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
5.4 Mexico Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
6 Europe Cancer Tumor Profiling Revenue by Countries
6.1 Europe Cancer Tumor Profiling Revenue by Countries (2015-2020)
6.2 Germany Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
6.3 UK Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
6.4 France Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
6.5 Russia Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
6.6 Italy Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Cancer Tumor Profiling Revenue by Countries
7.1 Asia-Pacific Cancer Tumor Profiling Revenue by Countries (2015-2020)
7.2 China Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
7.3 Japan Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
7.4 Korea Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
7.5 India Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
8 South America Cancer Tumor Profiling Revenue by Countries
8.1 South America Cancer Tumor Profiling Revenue by Countries (2015-2020)
8.2 Brazil Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
8.3 Argentina Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Cancer Tumor Profiling by Countries
9.1 Middle East & Africa Cancer Tumor Profiling Revenue by Countries (2015-2020)
9.2 Saudi Arabia Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
9.3 UAE Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
9.4 Egypt Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
9.5 South Africa Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Cancer Tumor Profiling Revenue and Market Share by Type (2015-2020)
10.2 Global Cancer Tumor Profiling Market Forecast by Type (2019-2024)
10.3 Next-generation Sequencing (NGS) Revenue Growth Rate (2015-2025)
10.4 Polymerase Chain Reaction (PCR) Revenue Growth Rate (2015-2025)
10.5 Immunohistochemistry (IHC) Revenue Growth Rate (2015-2025)
10.6 In Situ Hybridization (ISH) Revenue Growth Rate (2015-2025)
10.7 Microarray Revenue Growth Rate (2015-2025)
10.8 Others Revenue Growth Rate (2015-2025)
11 Global Cancer Tumor Profiling Market Segment by Application
11.1 Global Cancer Tumor Profiling Revenue Market Share by Application (2015-2020)
11.2 Cancer Tumor Profiling Market Forecast by Application (2019-2024)
11.3 Personalized Medicine Revenue Growth (2015-2020)
11.4 Diagnostics Revenue Growth (2015-2020)
11.5 Biomarker Discovery Revenue Growth (2015-2020)
11.6 Prognostics Revenue Growth (2015-2020)
11.7 Research Applications Revenue Growth (2015-2020)
12 Global Cancer Tumor Profiling Market Size Forecast (2021-2025)
12.1 Global Cancer Tumor Profiling Market Size Forecast (2021-2025)
12.2 Global Cancer Tumor Profiling Market Forecast by Regions (2021-2025)
12.3 North America Cancer Tumor Profiling Revenue Market Forecast (2021-2025)
12.4 Europe Cancer Tumor Profiling Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Cancer Tumor Profiling Revenue Market Forecast (2021-2025)
12.6 South America Cancer Tumor Profiling Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Cancer Tumor Profiling Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Cancer Tumor Profiling Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cancer Tumor Profiling by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cancer Tumor Profiling Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Cancer Tumor Profiling Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Qiagen N.V. Corporate Information, Location and Competitors
Table 6. Qiagen N.V. Cancer Tumor Profiling Major Business
Table 7. Qiagen N.V. Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 8. Qiagen N.V. SWOT Analysis
Table 9. Qiagen N.V. Cancer Tumor Profiling Product and Solutions
Table 10. Qiagen N.V. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Hologic Gen-Probe Corporate Information, Location and Competitors
Table 12. Hologic Gen-Probe Cancer Tumor Profiling Major Business
Table 13. Hologic Gen-Probe Cancer Tumor Profiling Total Revenue (USD Million) (2018-2019)
Table 14. Hologic Gen-Probe SWOT Analysis
Table 15. Hologic Gen-Probe Cancer Tumor Profiling Product and Solutions
Table 16. Hologic Gen-Probe Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Illumina Inc. Corporate Information, Location and Competitors
Table 18. Illumina Inc. Cancer Tumor Profiling Major Business
Table 19. Illumina Inc. Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 20. Illumina Inc. SWOT Analysis
Table 21. Illumina Inc. Cancer Tumor Profiling Product and Solutions
Table 22. Illumina Inc. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Roche Molecular Systems Inc. Corporate Information, Location and Competitors
Table 24. Roche Molecular Systems Inc. Cancer Tumor Profiling Major Business
Table 25. Roche Molecular Systems Inc. Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 26. Roche Molecular Systems Inc. SWOT Analysis
Table 27. Roche Molecular Systems Inc. Cancer Tumor Profiling Product and Solutions
Table 28. Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Genomic Health Inc. Corporate Information, Location and Competitors
Table 30. Genomic Health Inc. Cancer Tumor Profiling Major Business
Table 31. Genomic Health Inc. Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 32. Genomic Health Inc. SWOT Analysis
Table 33. Genomic Health Inc. Cancer Tumor Profiling Product and Solutions
Table 34. Genomic Health Inc. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Abott Molecular Corporate Information, Location and Competitors
Table 36. Abott Molecular Cancer Tumor Profiling Major Business
Table 37. Abott Molecular Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 38. Abott Molecular SWOT Analysis
Table 39. Abott Molecular Cancer Tumor Profiling Product and Solutions
Table 40. Abott Molecular Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Siemens Healthineers Corporate Information, Location and Competitors
Table 42. Siemens Healthineers Cancer Tumor Profiling Major Business
Table 43. Siemens Healthineers Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 44. Siemens Healthineers SWOT Analysis
Table 45. Siemens Healthineers Cancer Tumor Profiling Product and Solutions
Table 46. Siemens Healthineers Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. HTG Molecular Diagnostic Corporate Information, Location and Competitors
Table 48. HTG Molecular Diagnostic Cancer Tumor Profiling Major Business
Table 49. HTG Molecular Diagnostic Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 50. HTG Molecular Diagnostic SWOT Analysis
Table 51. HTG Molecular Diagnostic Cancer Tumor Profiling Product and Solutions
Table 52. HTG Molecular Diagnostic Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. NeoGenomics Laboratories Corporate Information, Location and Competitors
Table 54. NeoGenomics Laboratories Cancer Tumor Profiling Major Business
Table 55. NeoGenomics Laboratories Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 56. NeoGenomics Laboratories SWOT Analysis
Table 57. NeoGenomics Laboratories Cancer Tumor Profiling Product and Solutions
Table 58. NeoGenomics Laboratories Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. BD Biosciences Corporate Information, Location and Competitors
Table 60. BD Biosciences Cancer Tumor Profiling Major Business
Table 61. BD Biosciences Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 62. BD Biosciences SWOT Analysis
Table 63. BD Biosciences Cancer Tumor Profiling Product and Solutions
Table 64. BD Biosciences Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. V., Strand Corporate Information, Location and Competitors
Table 66. V., Strand Cancer Tumor Profiling Major Business
Table 67. V., Strand Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 68. V., Strand SWOT Analysis
Table 69. V., Strand Cancer Tumor Profiling Product and Solutions
Table 70. V., Strand Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Agendia Corporate Information, Location and Competitors
Table 72. Agendia Cancer Tumor Profiling Major Business
Table 73. Agendia Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 74. Agendia SWOT Analysis
Table 75. Agendia Cancer Tumor Profiling Product and Solutions
Table 76. Agendia Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Claris Life Sciences Corporate Information, Location and Competitors
Table 78. Claris Life Sciences Cancer Tumor Profiling Major Business
Table 79. Claris Life Sciences Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 80. Claris Life Sciences SWOT Analysis
Table 81. Claris Life Sciences Cancer Tumor Profiling Product and Solutions
Table 82. Claris Life Sciences Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. ApoCell Corporate Information, Location and Competitors
Table 84. ApoCell Cancer Tumor Profiling Major Business
Table 85. ApoCell Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 86. ApoCell SWOT Analysis
Table 87. ApoCell Cancer Tumor Profiling Product and Solutions
Table 88. ApoCell Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Foundation Medicine, Inc Corporate Information, Location and Competitors
Table 90. Foundation Medicine, Inc Cancer Tumor Profiling Major Business
Table 91. Foundation Medicine, Inc Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 92. Foundation Medicine, Inc SWOT Analysis
Table 93. Foundation Medicine, Inc Cancer Tumor Profiling Product and Solutions
Table 94. Foundation Medicine, Inc Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Personal Genome Diagnostics, Inc. Corporate Information, Location and Competitors
Table 96. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Major Business
Table 97. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 98. Personal Genome Diagnostics, Inc. SWOT Analysis
Table 99. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Product and Solutions
Table 100. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. GenScript Corporate Information, Location and Competitors
Table 102. GenScript Cancer Tumor Profiling Major Business
Table 103. GenScript Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 104. GenScript SWOT Analysis
Table 105. GenScript Cancer Tumor Profiling Product and Solutions
Table 106. GenScript Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Contextual Genomics Cancer Tumor Profiling Type and Application
Table 108. Contextual Genomics Cancer Tumor Profiling Major Business
Table 109. Contextual Genomics Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 110. Contextual Genomics SWOT Analysis
Table 111. Contextual Genomics Cancer Tumor Profiling Product and Solutions
Table 112. Contextual Genomics Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. Perthera, Inc. Corporate Information, Location and Competitors
Table 114. Perthera, Inc. Cancer Tumor Profiling Major Business
Table 115. Perthera, Inc. Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)
Table 116. Perthera, Inc. SWOT Analysis
Table 117. Perthera, Inc. Cancer Tumor Profiling Product and Solutions
Table 118. Perthera, Inc. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 119. Global Cancer Tumor Profiling Revenue (Million USD) by Players (2015-2020)
Table 120. Global Cancer Tumor Profiling Revenue Share by Players (2015-2020)
Table 121. Global Cancer Tumor Profiling Revenue (Million USD) by Regions (2015-2020)
Table 122. Global Cancer Tumor Profiling Revenue Market Share by Regions (2015-2020)
Table 123. North America Cancer Tumor Profiling Revenue by Countries (2015-2020)
Table 124. North America Cancer Tumor Profiling Revenue Market Share by Countries (2015-2020)
Table 125. Europe Cancer Tumor Profiling Revenue (Million USD) by Countries (2015-2020)
Table 126. Asia-Pacific Cancer Tumor Profiling Revenue (Million USD) by Countries (2015-2020)
Table 127. South America Cancer Tumor Profiling Revenue by Countries (2015-2020)
Table 128. South America Cancer Tumor Profiling Revenue Market Share by Countries (2015-2020)
Table 129. Middle East and Africa Cancer Tumor Profiling Revenue (Million USD) by Countries (2015-2020)
Table 130. Middle East and Africa Cancer Tumor Profiling Revenue Market Share by Countries (2015-2020)
Table 131. Global Cancer Tumor Profiling Revenue (Million USD) by Type (2015-2020)
Table 132. Global Cancer Tumor Profiling Revenue Share by Type (2015-2020)
Table 133. Global Cancer Tumor Profiling Revenue Forecast by Type (2021-2025)
Table 134. Global Cancer Tumor Profiling Revenue by Application (2015-2020)
Table 135. Global Cancer Tumor Profiling Revenue Share by Application (2015-2020)
Table 136. Global Cancer Tumor Profiling Revenue Forecast by Application (2021-2025)
Table 137. Global Cancer Tumor Profiling Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Cancer Tumor Profiling Picture
Figure 2. Global Cancer Tumor Profiling Revenue Market Share by Type in 2019
Figure 3. Next-generation Sequencing (NGS) Picture
Figure 4. Polymerase Chain Reaction (PCR) Picture
Figure 5. Immunohistochemistry (IHC) Picture
Figure 6. In Situ Hybridization (ISH) Picture
Figure 7. Microarray Picture
Figure 8. Others Picture
Figure 9. Cancer Tumor Profiling Revenue Market Share by Application in 2019
Figure 10. Personalized Medicine Picture
Figure 11. Diagnostics Picture
Figure 12. Biomarker Discovery Picture
Figure 13. Prognostics Picture
Figure 14. Research Applications Picture
Figure 15. Global Cancer Tumor Profiling Revenue (USD Million) and Growth Rate (2015-2025)
Figure 16. North America Cancer Tumor Profiling Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Europe Cancer Tumor Profiling Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Asia-Pacific Cancer Tumor Profiling Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. South America Cancer Tumor Profiling Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Middle East and Africa Cancer Tumor Profiling Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Cancer Tumor Profiling Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Cancer Tumor Profiling Revenue Share by Players in 2019
Figure 23. Global Top 5 Players Cancer Tumor Profiling Revenue Market Share in 2019
Figure 24. Global Top 10 Players Cancer Tumor Profiling Revenue Market Share in 2019
Figure 25. Key Players Market Share Trend
Figure 26. Global Cancer Tumor Profiling Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 27. Global Cancer Tumor Profiling Revenue Market Share by Regions (2015-2020)
Figure 28. Global Cancer Tumor Profiling Revenue Market Share by Regions in 2018
Figure 29. North America Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 30. Europe Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 31. Asia-Pacific Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 32. South America Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 33. Middle East and Africa Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 34. North America Cancer Tumor Profiling Revenue Market Share by Countries (2015-2020)
Figure 35. North America Cancer Tumor Profiling Revenue Market Share by Countries in 2019
Figure 36. USA Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 37. Canada Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 38. Mexico Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 39. Europe Cancer Tumor Profiling Revenue Market Share by Countries (2015-2020)
Figure 40. Europe Cancer Tumor Profiling Revenue Market Share by Countries in 2019
Figure 41. Germany Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 42. UK Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 43. France Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 44. Russia Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 45. Italy Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Cancer Tumor Profiling Revenue Market Share by Countries (2015-2020)
Figure 47. Asia-Pacific Cancer Tumor Profiling Revenue Market Share by Countries in 2019
Figure 48. China Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 49. Japan Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 50. Korea Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 51. India Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 52. Southeast Asia Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 53. South America Cancer Tumor Profiling Revenue Market Share by Countries (2015-2020)
Figure 54. South America Cancer Tumor Profiling Revenue Market Share by Countries in 2019
Figure 55. Brazil Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 56. Argentina Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 57. Middle East and Africa Cancer Tumor Profiling Revenue Market Share by Countries (2015-2020)
Figure 58. Middle East and Africa Cancer Tumor Profiling Revenue Market Share by Countries in 2019
Figure 59. Saudi Arabia Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 60. UAE Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 61. Egypt Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 62. South Africa Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)
Figure 63. Global Cancer Tumor Profiling Revenue Share by Type (2015-2020)
Figure 64. Global Cancer Tumor Profiling Revenue Share by Type in 2019
Figure 65. Global Cancer Tumor Profiling Market Share Forecast by Type (2021-2025)
Figure 66. Global Next-generation Sequencing (NGS) Revenue Growth Rate (2015-2020)
Figure 67. Global Polymerase Chain Reaction (PCR) Revenue Growth Rate (2015-2020)
Figure 68. Global Immunohistochemistry (IHC) Revenue Growth Rate (2015-2020)
Figure 69. Global In Situ Hybridization (ISH) Revenue Growth Rate (2015-2020)
Figure 70. Global Microarray Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Cancer Tumor Profiling Revenue Share by Application (2015-2020)
Figure 73. Global Cancer Tumor Profiling Revenue Share by Application in 2019
Figure 74. Global Cancer Tumor Profiling Market Share Forecast by Application (2021-2025)
Figure 75. Global Personalized Medicine Revenue Growth Rate (2015-2020)
Figure 76. Global Diagnostics Revenue Growth Rate (2015-2020)
Figure 77. Global Biomarker Discovery Revenue Growth Rate (2015-2020)
Figure 78. Global Prognostics Revenue Growth Rate (2015-2020)
Figure 79. Global Research Applications Revenue Growth Rate (2015-2020)
Figure 80. Global Cancer Tumor Profiling Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 81. Global Cancer Tumor Profiling Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 82. Global Cancer Tumor Profiling Revenue Market Share Forecast by Regions (2021-2025)
Figure 83. North America Cancer Tumor Profiling Revenue Market Forecast (2021-2025)
Figure 84. Europe Cancer Tumor Profiling Revenue Market Forecast (2021-2025)
Figure 85. Asia-Pacific Cancer Tumor Profiling Revenue Market Forecast (2021-2025)
Figure 86. South America Cancer Tumor Profiling Revenue Market Forecast (2021-2025)
Figure 87. Middle East and Africa Cancer Tumor Profiling Revenue Market Forecast (2021-2025)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
腫瘍治療フィールド（TTFields）の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Tumor Treating Fields (TTFields) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tumor Treati…- 固形腫瘍治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Solid Tumor Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.1% in the forecast period of 2020 to 2025 and will expected to reach USD 156810 million by 2025, from USD 114670 million in 2019. The Solid Tumor…
- 性腺性腺間質腫瘍治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Sex Cord Gonadal Stromal Tumor Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Sex …
- 大腸がんの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Colorectal Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.1% in the forecast period of 2020 to 2025 and will expected to reach USD 9118.8 million by 2025, from USD 8386.1 million in 2019. The Colorectal Cancer …
- 移行上皮がん治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Transitional Cell Cancer Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Transit…